Insufficient scRNA-seq data for expression of PTH at single-cell level.
Insufficient scRNA-seq data for expression of PTH at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 38% | 12.73 | 135 / 359 | 2% | 0.04 | 5 / 286 |
pancreas | 9% | 2.54 | 29 / 328 | 1% | 0.04 | 1 / 178 |
thymus | 8% | 5884.40 | 55 / 653 | 1% | 0.43 | 5 / 605 |
bladder | 5% | 5.52 | 1 / 21 | 1% | 0.03 | 3 / 504 |
uterus | 4% | 4.00 | 6 / 170 | 1% | 0.04 | 6 / 459 |
esophagus | 2% | 1.99 | 36 / 1445 | 2% | 0.03 | 3 / 183 |
intestine | 3% | 1.96 | 25 / 966 | 0% | 0.00 | 1 / 527 |
liver | 2% | 0.85 | 5 / 226 | 0% | 0.02 | 1 / 406 |
ovary | 2% | 2.43 | 4 / 180 | 0% | 0.02 | 1 / 430 |
skin | 1% | 1.31 | 24 / 1809 | 0% | 0.89 | 2 / 472 |
lung | 1% | 0.82 | 4 / 578 | 1% | 0.07 | 12 / 1155 |
adrenal gland | 2% | 1.29 | 4 / 258 | 0% | 0 | 0 / 230 |
blood vessel | 1% | 0.88 | 18 / 1335 | 0% | 0 | 0 / 0 |
brain | 1% | 0.31 | 23 / 2642 | 0% | 0.01 | 3 / 705 |
spleen | 1% | 1.06 | 3 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 0.81 | 11 / 929 | 0% | 0 | 0 / 0 |
breast | 1% | 0.96 | 4 / 459 | 0% | 0.04 | 3 / 1118 |
adipose | 1% | 0.80 | 12 / 1204 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.01 | 8 / 901 |
heart | 1% | 0.57 | 6 / 861 | 0% | 0 | 0 / 0 |
prostate | 0% | 0.65 | 1 / 245 | 0% | 0.00 | 1 / 502 |
muscle | 0% | 0.56 | 3 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0055062 | Biological process | phosphate ion homeostasis |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0071107 | Biological process | response to parathyroid hormone |
GO_0010468 | Biological process | regulation of gene expression |
GO_0046326 | Biological process | positive regulation of glucose import |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0008628 | Biological process | hormone-mediated apoptotic signaling pathway |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0009967 | Biological process | positive regulation of signal transduction |
GO_0010288 | Biological process | response to lead ion |
GO_0060732 | Biological process | positive regulation of inositol phosphate biosynthetic process |
GO_0006874 | Biological process | intracellular calcium ion homeostasis |
GO_0045471 | Biological process | response to ethanol |
GO_0090290 | Biological process | positive regulation of osteoclast proliferation |
GO_0007267 | Biological process | cell-cell signaling |
GO_0048873 | Biological process | homeostasis of number of cells within a tissue |
GO_0032331 | Biological process | negative regulation of chondrocyte differentiation |
GO_0045725 | Biological process | positive regulation of glycogen biosynthetic process |
GO_0046058 | Biological process | cAMP metabolic process |
GO_0046686 | Biological process | response to cadmium ion |
GO_0071774 | Biological process | response to fibroblast growth factor |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0071864 | Biological process | positive regulation of cell proliferation in bone marrow |
GO_0009059 | Biological process | macromolecule biosynthetic process |
GO_0030282 | Biological process | bone mineralization |
GO_1900158 | Biological process | negative regulation of bone mineralization involved in bone maturation |
GO_0045453 | Biological process | bone resorption |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0001501 | Biological process | skeletal system development |
GO_0007266 | Biological process | Rho protein signal transduction |
GO_0010960 | Biological process | magnesium ion homeostasis |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0030501 | Biological process | positive regulation of bone mineralization |
GO_0033280 | Biological process | response to vitamin D |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0071866 | Biological process | negative regulation of apoptotic process in bone marrow cell |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0051428 | Molecular function | peptide hormone receptor binding |
GO_0048018 | Molecular function | receptor ligand activity |
GO_0031857 | Molecular function | type 1 parathyroid hormone receptor binding |
GO_0005179 | Molecular function | hormone activity |
GO_0031856 | Molecular function | parathyroid hormone receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PTH |
Protein name | Parathyroid hormone (PTH) (Parathormone) (Parathyrin) |
Synonyms | |
Description | FUNCTION: PTH elevates calcium level by dissolving the salts in bone and preventing their renal excretion. Stimulates [1-14C]-2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblastic cells. . |
Accessions | P01270 ENST00000282091.6 ENST00000529816.1 |